Rituximab in the treatment of refractory pulmonary sarcoidosis

Eur Respir J. 2014 May;43(5):1525-8. doi: 10.1183/09031936.00224513. Epub 2014 Jan 31.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Aged
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Rituximab
  • Sarcoidosis, Pulmonary / drug therapy*
  • Spirometry / methods
  • Treatment Outcome
  • Vital Capacity

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab

Associated data

  • ClinicalTrials.gov/NCT00855205